HS Publication Explainers

Dr. Kirby is a dermatologist and clinician-researcher at Penn State Hershey. She earned her medical degree from the University of Virginia, then completed her dermatology residency at the University of Pennsylvania. In her clinical and research work, she is interested in acneiform conditions, especially, hidradenitis suppurativa, including its effects on people, outcome measurement, and pathomechanisms. She is the principal investigator of a number of clinical research trials.

Disclosures: Dr Kirby has been on advisory boards for: AbbVie, Incyte, Novartis and UCB, and has been a consultant for: AbbVie, Alumis, DermTech, Guidepoint, Incyte, Insmed, Janssen, Moonlake, Novartis and UCB. Dr Kirby has also been a speaker for: AbbVie, Novartis, UCB and Janssen.

Dr Daveluy is an Associate Professor and Program Director at Wayne State University in Detroit, Michigan. He earned a Bachelor's in Science from Michigan State University and completed medical school and his dermatology residency at Wayne State University. He holds special interests in teledermatology, noninvasive skin imaging, skin of color, integrative dermatology, and complex medical dermatology, including hidradenitis suppurativa. He is active on American Academy of Dermatology (AAD) committees, including Performance Measure and DataDerm Oversight. He is the past president of the Wayne County Medical Society and Michigan Dermatological Society. He serves on the editorial board for the Journal of the AAD (JAAD) and is building a growing body of publications of his own. He lives across the border in Windsor, Ontario, Canada with his husband.

Disclosures: Dr Daveluy reports speaker and consultant fees from Abbvie, UCB and Novartis. He has received research grants from Abbvie, UCB and Pfizer.

Dr Jennifer Hsiao is an Associate Clinical Professor of Dermatology at the University of Southern California, where she directs a Hidradenitis Suppurativa Specialty Clinic.

Disclosures: Dr Jennifer Hsiao has served as a consultant for Aclaris, Boehringer Ingelheim, Novartis, and UCB; and as a speaker and consultant for AbbVie.

Dr Haley Naik is Associate Professor of Dermatology, Vice Chair for Health Equity and Director of the Hidradenitis Suppurativa Program at the University of California, San Francisco, USA. She completed medical school and dermatology residency at Harvard Medical School, and went on to complete a postdoctoral clinical research fellowship at the National Institutes of Health and received a Master’s of Health Sciences from Duke University. She established the UCSF Hidradenitis Suppurativa Program in 2016, and the multicentre Hidradenitis Suppurativa PRospective Observational REgistry and bioSpecimen repoSitory (HS PROGRESS) in 2018.

Disclosures: Dr Haley Naik has received grant support from AbbVie; consulting fees from 23andme, AbbVie, Aristea Therapeutics, Boehringer Ingelheim, DAVA Oncology, Medscape, Nimbus Therapeutics, Novartis, Sonoma Biotherapeutics, and Union Chimique Belge’s (UCB); investigator fees from Pfizer; and holds shares in Radera, Inc. She is also an Associate Editor for JAMA Dermatology and a board member of the Hidradenitis Suppurativa Foundation.

Dr Irene Lara-Corrales is an Associate Professor of Paediatrics at the University of Toronto and a staff physician in Paediatric Dermatology at the Hospital for Sick Children in Toronto, Canada. She completed her medical training and paediatric residency at the University of Costa Rica, in San Jose, Costa Rica, and her paediatric dermatology training at the Hospital for Sick Children. She is involved in numerous clinical and research endeavours, as well as in teaching commitments. She co-directs the Genodermatoses, Epidermolysis Bullosa, Vascular Tumours and Café-au-Lait Screening clinics at SickKids. She is currently the Paediatric Dermatology Fellowship director at SickKids. Her research interests include genodermatoses, inflammatory diseases and vascular anomalies.

Disclosures: Professor Lara-Corrales has been in receipt of grants or research support from AbbVie, Arcutis, Clementia, EB Medical Research Foundation, EB Research Partnership, Eli Lilly, La Roche Posse, Mayne Pharma, Physicians Services Incorporated Foundation, Regeneron, Sanofi Genzyme, SkIN Canada, and Timber. She is in receipt of honoraria or consultation fees from Abeona, Avicanna, Eli Lilly, Ipsen, Novartis, and Sanofi Genzyme. She has participated in company-sponsored speaker’s bureau for AbbVie, Eli Lilly, and Sanofi Genzyme. Professor Lara-Corrales has received other support as a board member of DeBRA Canada and Camp Liberté and Children International Summer Villages.

Dr Tiffany Mayo is a board-certified dermatologist and Associate Professor of Dermatology at The University of Alabama at Birmingham, USA. Her interests include skin colour, hair and scalp disorders, HS and clinical trials. She leads the Ethnic Skin and Hair Clinic and is Director of the Dermatology Clinical Research Unit. She also serves as Department Vice Chair of Diversity, Equity, and Inclusion.

Disclosures: Investigator for Acelyrin, Bristol Myers Squibb, ChemoCentryx, Galderma, Janssen, Lilly, and Pfizer. Consultant for AbbVie, Arcutis Biotherapeutics, Bodewell, Bristol Myers Squibb, Janssen, Leo, Lilly, Novartis, and Pfizer.